SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-23-036721
Filing Date
2023-10-10
Accepted
2023-10-10 15:55:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 14434
2 proxy_001.jpg GRAPHIC 679643
3 proxy_002.jpg GRAPHIC 436785
  Complete submission text file 0001493152-23-036721.txt   1553186
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39717 | Film No.: 231317857
SIC: 2834 Pharmaceutical Preparations